A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )

Clinical trial NCT07417189 · RECRUITING

Trial details

NCT number: NCT07417189
Sponsor: Abbisko Therapeutics Co, Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors, Adult

Start date: 2026-03-02
Primary completion: 2028-12-30
Enrollment: 401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.